AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 286: R1156-R1166, 2004. First published February 12, 2004; doi:10.1152/ajpregu.00486.2003
0363-6119/04 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/6/R1156    most recent
00486.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feleder, C.
Right arrow Articles by Blatteis, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feleder, C.
Right arrow Articles by Blatteis, C. M.

INFLAMMATION, CYTOKINES, AND TEMPERATURE REGULATION

Preoptic {alpha}1- and {alpha}2-noradrenergic agonists induce, respectively, PGE2-independent and PGE2-dependent hyperthermic responses in guinea pigs

Carlos Feleder, Vit Perlik, and Clark M. Blatteis

Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee 38163

Submitted 25 August 2003 ; accepted in final form 8 February 2004


   ABSTRACT
TOP
 ABSTRACT
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
We have shown previously that norepinephrine (NE) microdialyzed into the preoptic area (POA) of conscious guinea pigs stimulates local PGE2 release. To identify the cyclooxygenase (COX) isozyme that catalyzes the production of this PGE2 and the adrenoceptor (AR) subtype that mediates this effect, we microdialyzed for 6 h NE, cirazoline ({alpha}1-AR agonist), and clonidine ({alpha}2-AR agonist) into the POA of conscious guinea pigs pretreated intrapreoptically (intra-POA) with SC-560 (COX-1 inhibitor) or nimesulide or MK-0663 (COX-2 inhibitors) and measured the animals' core temperature (Tc) and intra-POA PGE2 responses. Cirazoline induced Tc rises promptly after the onset of its dialysis without altering PGE2 levels. NE and clonidine caused early falls followed by late rises of Tc; intra-POA PGE2 levels were closely correlated with this thermal course. COX-1 inhibition attenuated the clonidine-induced Tc and PGE2 falls but not the NE-elicited hyperthermia, but COX-2 inhibition suppressed both the clonidine- and NE-induced Tc and PGE2 rises. Coinfused cirazoline and clonidine reproduced the late Tc rise of clonidine but not its early fall and also not the early rise produced by cirazoline; on the other hand, the PGE2 responses were similar to those to NE. Prazosin ({alpha}1-AR antagonist) and yohimbine ({alpha}2-AR antagonist) blocked the effects of their respective agonists. These results indicate that {alpha}1- and {alpha}2-AR agonists microdialyzed into the POA of conscious guinea pigs evoke distinct Tc responses: {alpha}1-AR activation produces quick, PGE2-independent Tc rises, and {alpha}2-AR stimulation causes an early Tc fall and a late, COX-2/PGE2-dependent Tc rise.

thermoregulation; cyclooxygenase inhibitors; prostaglandin E2; noradrenergic agonists and antagonists; care temperature; norepinephrine

THERE IS MUCH EVIDENCE that norepinephrine (NE) and prostaglandin (PG) E2 interact in many tissues, including nervous tissue (33). For example, an intimate association between NE and PGE2 is well documented in the peripheral nervous system (21); to wit, the stimulation of sympathetic neurons induces the postsynaptic release of PGE2, which then limits the further presynaptic release of NE, thereby modulating the activity of noradrenergic neurons. It is also well documented that NE induces PGE2 synthesis in brain tissue (23, 60) where its feedback inhibition of the presynaptic release of NE has been similarly documented (3, 13, 54).

In conscious guinea pigs, NE microinjected into the preoptic-anterior hypothalamic area [POA, the locus of the thermal controller (7)] evokes body (core) temperature (Tc) rises (75, 47). Electrical stimulation of the ascending noradrenergic system in the brain stem yields the same result (67), whereas chemical sympathectomy abrogates this response (66). PGE2 microinjected into the POA also is thermogenic (5). NE is quickly degraded and removed from the brain whereas PGE2 is removed much more slowly (74), so that the action of the latter may outlast the effect of the former. Because the hyperthermia induced in cats by intracerebroventricularly injected NE was inhibited by pretreatment with the antipyretic aspirin, a cyclooxygenase (COX) inhibitor, the notion was advanced that the hyperthermic action of NE may be exerted through PGE2 (30). Others (27), however, have suggested that PGE2 may be thermogenic through NE because the destruction by 6-hydroxydopamine of the noradrenergic nerve terminals in the POA of rabbits attenuated the rise in Tc produced by intravenously injected LPS, while still others (40) found no mutual interaction between NE and PGE2.

There is thus no consensus as yet as to how NE and PGE2 may interact in the POA during fever. The issue has relevance to current hypotheses of the mechanism of fever induction. Thus it is well documented that peripheral pyrogens activate noradrenergic pathways in the brain (14, 26) and that NE is released in the POA in conjunction with the febrile response (31, 38). The involvement of PGE2 in fever production is now all but axiomatic, but the dynamics and source of the pyrogen-induced elevation of preoptic PGE2 levels are still controversial (5). If NE were the direct stimulus for its increased production, it might be expected from the preceding that it would begin promptly and that, in turn, the elevated PGE2 levels would inhibit the further release of NE. Furthermore, to support the hypothesis of such an interaction in fever production, it would be necessary to show that the induction of PGE2 by NE is mediated in the POA by COX-2, since it is now generally agreed that COX-2 is the isoform of the enzyme that catalyzes the production of PGE2 in response to pyrogenic stimuli (29, 48, 64, 77).

The present study was undertaken, therefore, to test the hypothesis that COX-2 is the isozyme that mediates the NE-enhanced expression of PGE2 in the POA and to identify the adrenoceptor (AR) subtype(s) that may be involved in this effect. Because physiological stimuli cause NE to be released from its neuronal terminals not in a single burst but in repetitive pulses over a varying time until its stores become exhausted (2, 65) and because the repetitive pattern of delivery is better approximated by microdialysis, when NE is presented to the tissue over a longer duration, than by microinjection, when it is presented acutely in a microdroplet (47), we microdialyzed rather than microinjected NE and specific {alpha}1- and {alpha}2-AR agonists and antagonists into the POA of conscious guinea pigs pretreated intrapreoptically (intra-POA) with selective COX-1 and COX-2 inhibitors and measured the animals' Tc and POA PGE2 levels. Our results validate the hypothesis and reveal additionally that the {alpha}-AR agonists of NE exert different effects. The activation of {alpha}1-ARs evokes very promptly a Tc rise with no associated PGE2 release, whereas the activation of {alpha}2-ARs induces an initial Tc fall followed later by a Tc rise, the upregulation of COX-2 and the consequent production of PGE2. However, when administered together (to mimic NE), the hyperthermic effect of {alpha}1-AR stimulation is nullified by the initial hypothermic effect of the simultaneous activation of {alpha}2-ARs. COX-1 does not appear to have a demonstrable role in the Tc rise caused by NE under these conditions but may be involved in the {alpha}2-AR-mediated Tc fall.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 
Animals

Male, pathogen-free, Hartley guinea pigs (301–350 g; Charles River Laboratories, Wilmington, MA) were used in these experiments. The animals were quarantined for 1 wk, three to a cage, before any experimental use. Tap water and food (Agway Prolab guinea pig diet) were available ad libitum. The ambient temperature (Ta) in the animal room was 23 ± 1°C; light and darkness alternated, with light on from 0600 to 1800. After quarantine, to moderate the psychological stress associated with the experiments, the animals were trained to the experimental procedure for 1 wk (daily for 4 h) by handling and placement in individual, locally fabricated, semicircular wire mesh confiners designed to prevent their turning around and to minimize their forward and backward movements, but without causing restraint stress; rodents readily adapt to such confinement and show no sign of discomfort or anxiety (56). All animal protocols were approved by the University of Tennessee Health Science Center Animal Care and Use Committee and fully conform with the standards established by the US Animal Welfare Act and by the documents entitled "Guiding Principles for Research Involving Animals and Human Beings" (1).

Surgical Procedure

All the animals received a prophylactic injection of the antibiotic gentamicin sulfate (6 mg/kg im) immediately before surgery and once a day for the following 2 days. Microdialysis guide cannulas were implanted by methods described previously (46, 47). Briefly, the guinea pigs were anesthetized with ketamine-xylazine (35–5 mg/kg im). Under aseptic conditions, a sterile, 17-mm-long, 17-gauge, thin-walled stainless steel guide cannula with a tightly fitting indwelling stylet was implanted stereotaxically into the left medial POA [anteroposterior = 11.6 mm, lateral = 1.0 mm, ventral = –9.0 mm, according to the atlas of Luparello (32)] and fixed to the skull with four self-tapping, miniature, stainless steel screws and dental acrylic cement. All the animals received fluid replacement therapy (5–10 ml of pyrogen-free saline sc) immediately after surgery and butorphanol (0.05 mg/kg twice a day) for postoperative pain control, as necessary. Training to the experimental procedure resumed 2 days postsurgery. Seven days were allowed for full recovery.

Drugs

The microdialysis perfusate and vehicle for all the drugs was sterile artificial cerebrospinal fluid (aCSF) for guinea pigs, prepared as previously described (60) with a final concentration (in mM) of 140.0 NaCl, 2.7 KCl, 1.0 MgCl2·2H2O, 1.2 CaCl2·2H2O, 2.0 Na2HPO4; osmolality of 290 mosmol/kgH2O; and pH of 7.4, adjusted with 85% H3PO4. The following solutions were prepared just before use and stored in amber glass vials at room temperature: l-NE bitartrate (10 µg/µl), the NE antioxidant ascorbic acid (0.1% in aCSF), the {alpha}1-AR agonist cirazoline (1 µg/µl), the {alpha}1-AR antagonist prazosin (1 µg/µl), the {alpha}2-AR agonist clonidine (2 µg/µl), the {alpha}2-AR antagonist yohimbine (1 µg/µl), the selective COX-1 inhibitor SC-560 (5 µg/µl), the selective COX-2 inhibitors MK-0663 (0.5 µg/µl) and nimesulide (1 µg/µl), and their solvent DMSO (6% in aCSF). These concentrations were selected on the basis of our previous studies (47, 49–51, 55, 60). It should be noted in this regard that only 10% of the doses microdialyzed at 2 µl/min, as in this study, diffuses into the POA (47). MK-0663 was generously supplied by Merck Frosst Canada (Kirckland, Quebec, Canada); cirazoline was purchased from Tocris (Ellisville, MO). All the other drugs were purchased from Sigma-Aldrich (St. Louis, MO).

Microdialysis Probes

The microdialysis probes used in this study were adapted from the concentric design of Torto et al. (68) and constructed by us. Thus a 20-cm-long silica capillary (ID 50 µm, OD 125 µm; Polymicro Technologies, Phoenix, AZ) was inserted within a 15-cm-long piece of polyethylene tubing [PE 50 (ID 0.58 mm, OD 0.965 mm); Intramedic Clay Adams, Becton Dickinson, Sparks, MD] so that 2.1 cm of the capillary protruded from the distal end of the outer tubing. Next, a 2.5-cm-long, 26-gauge stainless steel tube (ID 75 µm, OD 154 µm; Polymicro Technologies, Phoenix, AZ) was slipped over the capillary a distance of 0.5 cm into the PE tubing so that 2 cm of the tube remained outside of the PE tubing and ~1 mm of the capillary extended beyond the distal tip of the tube. A nitrocellulose hollow fiber dialysis membrane (10-kDa nominal molecular mass cutoff, OD 150 µm, 2 mm fiber; Spectra/Por, Spectrum, Laguna Hills, CA.) was then fitted over the protruding capillary and its distal end sealed with a droplet of "5-min" epoxy (Devcon, Danvers, MA). The inner capillary thus served as the outlet and the PE tubing as the inlet of the perfusion medium.

Two hours before an experiment, the indwelling stylets of the guide cannulas were replaced by sterile microdialysis probes, so that their dialysis membrane tips protruded exactly 1 mm beyond the guide cannulas. They were fixed to the skull with tissue adhesive and immediately perfused with sterile aCSF via sterile 1-ml tuberculin syringes clamped to a syringe pump (model A-99; Razel Scientific Instruments, Stamford, CT) as the driver; to run six animals simultaneously, the pushers of two pumps were modified so that each could accommodate three syringes at a time. The flow rate of the perfusion was 2 µl/min (46). A 90-min stabilization period preceded all the experimental treatments.

After an experiment, the guinea pigs were euthanized by isoflurane overdose, and the brains were quickly removed and stored in 10% phosphate-buffered Formalin for later histological verification of the placement of the dialysis probe tips. Localization of the center of the dialysis probe within 0.5 mm of the medial POA was regarded as the correct placement (Fig. 1). Only the data from animals with confirmed preoptic placement of the probes are included in this report.



View larger version (130K):
[in this window]
[in a new window]
  		Fig. 1. Photomicrograph of a coronal section through the forebrain of a guinea pig, showing the track of a microdialysis probe guide cannula implanted into the preoptic area (POA). The guide cannulas were placed 7 days before an experiment (see materials and methods for details). AC, anterior commissure; 3V, third ventricle; OC, optic chiasma.

 
Physiological Measurements

Seven days after surgery, the guinea pigs, fully conscious, were loosely restrained in their individual wire mesh confiners at Ta 23 ± 1°C. The Tc of the guinea pigs were monitored constantly and recorded at 2-min intervals for the duration of an experiment on a Macintosh Plus lMb microcomputer through an analog-to-digital converter, using precalibrated copper-constantan thermocouples inserted 5 cm into the colon. The data were displayed digitally on a monitor, printed on an ImageWriter printer, and stored on a diskette. The effluents from the microdialysate probes were collected over 30-min intervals continuously throughout the experiments. The PGE2 content of the samples was evaluated using a PGE2 enzyme immunoassay kit (no. 931–001; Assay Designs, Ann Arbor, MI). To obviate possible effects of circadian variations, all the experiments were begun at the same time of day (0830).

Experimental Designs

Experiment 1: NE effects on Tc. To determine the thermal effect of intra-POA NE and to identify the {alpha}-AR subtype(s) that may mediate this effect, we microdialyzed NE, cirazoline, clonidine, prazosin, or yohimbine into the POA of conscious guinea pigs for 6 h, or prazosin for 1 h followed by cirazoline for 5 h, or yohimbine for 1 h followed by clonidine for 5 h. Tc and preoptic PGE2 levels were measured as described earlier. The 6-h total duration of this procedure was chosen to align it with the temporal course of a prototypic endotoxic fever in conscious guinea pigs (60, 64).

Experiment 2: {alpha}2-ARs and COX. Because clonidine, but not cirazoline, induced Tc-associated POA PGE2 level changes (see results), to identify the COX isozyme presumptively involved in these effects, we microdialyzed SC-560, nimesulide, or MK-0663 for 1 h into the POA of conscious guinea pigs and clonidine for the following 5 h. Tc and preoptic PGE2 levels were determined as before. The effects of these COX inhibitors on Tc and PGE2 were also tested.

Experiment 3: validation of preoptic NE effects. To relate the results of experiments 1 and 2 to the actions of intra-POA NE, we microdialyzed for 1 h prazosin, yohimbine, or MK-0663 into the POA of conscious guinea pigs, followed for 5 h by NE. Tc and preoptic PGE2 levels were monitored as above.

Finally, to correlate the effects of NE to those evoked by the {alpha}1-AR and {alpha}2-AR agonists, but without the confounding effects of 0.1% ascorbate (low pH and antioxidant vehicle), we microdialyzed cirazoline and clonidine combined into a single solution intra-POA for 6 h. Tc and preoptic PGE2 levels were monitored as above.

Statistical Analyses

The results are reported here as means ± SE. The values of Tc are changes from basal values [initial Tc (Tci), the Tc at 2-min intervals averaged over the last 10 min of the preceding 90-min stabilization period] plotted at 6-min intervals. Latencies of Tc changes were defined as the intervals (in min) between the onset of a treatment (0 or 60 min) and the first Tc rise or fall greater than 0.2°C (i.e., the SD of the Tc of aCSF-treated guinea pigs) that continued uninterruptedly beyond ±0.5°C. The PGE2 data are expressed as changes relative to their values before a treatment (P0). A repeated-measures ANOVA was used to compare the Tc and PGE2 changes between groups; factor 1 was the between-groups factor (the treatment), and factor 2 was the within-subjects factor (the different sampling periods), followed, if significant differences were found, by a point-by-point Tukey-Kramer multiple comparison test. The analyses were performed using Instat 3 (Graph Pad Software; Instant Biostatistics, San Diego, CA). Each variable was considered to be independent. The 5% level of probability was accepted as statistically significant.


   RESULTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 GRANTS
 REFERENCES
 
Experiment 1: NE Effects on Tc

The intra-POA microdialysis of aCSF per se did not evoke any Tc and intra-POA PGE2 changes (Fig. 2, A and B). In contrast, aCSF + 0.1% ascorbic acid, the NE antioxidant, caused a prompt, statistically significant approximately –0.6°C decrease in Tc (latency: 45 ± 12 min); it reached its nadir in 120 min and then returned to its basal level by ~210 min. The levels of PGE2 in the microdialysate effluents, however, were not changed by this treatment (Fig. 2, C and D). NE + 0.1% ascorbic acid induced a biphasic thermal response. The first, a Tc fall, coincided in magnitude with that induced by ascorbic acid but lasted longer. It was followed by a second response, a Tc rise, that gradually began after ~120 min and peaked ~0.8°C above Tci, a statistically significant increase: this rise was maintained until the end of the experiment. Preoptic PGE2 levels increased significantly in these guinea pigs in approximate temporal correspondence with their Tc rises (Fig. 2, E and F).



View larger version (17K):
[in this window]
[in a new window]
  		Fig. 2. Effects on the body (core) temperature (Tc) and preoptic PGE2 levels, respectively, of artificial cerebrospinal fluid (aCSF; A and B), aCSF + ascorbic acid (C and D), and aCSF + ascorbic acid + norepinephrine (NE) (E and F) microdialyzed into the POA of conscious guinea pigs. Tc values are expressed as differences ({Delta}Tc) relative to their initial levels [Tci: average of the Tc over the last 10 min before treatment (time 0)]. P0, PGE2 value before treatment. Values are means ± SE; (n), no. of animals. *P < 0.05.

 
The microdialysis of cirazoline evoked a statistically significant Tc rise very quickly after the onset of its administration (latency: 15 ± 6 min). The maximum (~1°C) was attained in ~150 min, continued unaltered for ~2 h, and then gradually declined even though the perfusion was continuing. PGE2 levels, however, were not altered (Fig. 3, A and B). Prazosin perfused over the full 6 h of the experiment altered neither the Tc nor the PGE2 levels of the guinea pigs (Fig. 3, C and D), but prazosin administered for 1 h before cirazoline completely abolished the effect of cirazoline on Tc; PGE2 was not affected (Fig. 3, E and F).



View larger version (17K):
[in this window]
[in a new window]
  		Fig. 3. Effects on Tc and preoptic PGE2 levels, respectively, of the {alpha}1-adrenoceptor ({alpha}1-AR) agonist cirazoline (A and B), the selective {alpha}1-AR antagonist prazosin (C and D), and prazosin + cirazoline (E and F) microdialyzed into the POA of conscious guinea pigs. Abbreviations and conventions as in Fig. 2. *P < 0.05.

 
Clonidine induced a gradual, significant Tc fall followed by a rapid, significant Tc rise compared with aCSF alone (Fig. 2A). The Tc decline began almost immediately after the onset of the dialysis (latency: 15 ± 6 min) and reached approximately –0.8°C in ~160 min. It then increased progressively until the end of the experiment to ~1°C above Tci. Intra-POA PGE2 levels changed significantly in close correlation with the Tc changes (Fig. 4, A and B). The perfusion of yohimbine over the 6-h duration of the experiment affected neither the Tc nor the PGE2 levels of the guinea pigs (Fig. 4, C and D), but yohimbine administered for 1 h before clonidine completely abolished both the Tc and PGE2 falls and rises caused by clonidine alone (Fig. 4, E and F).



View larger version (17K):
[in this window]
[in a new window]
  		Fig. 4. Effects on Tc and preoptic PGE2 levels, respectively, of the {alpha}2-AR agonist clonidine (A and B), the {alpha}2-AR antagonist yohimbine (C and D), and yohimbine + clonidine (E and F) microdialyzed into the POA of conscious guinea pigs. Abbreviations and conventions as in Fig. 2. *P < 0.05.

 
Experiment 2: {alpha}2-ARs and COX

The microdialysis of SC-560 for 1 h before that of clonidine did not alter the late effects of clonidine on Tc and intra-POA PGE2 levels. However, it inhibited its early effects on these variables. PGE2 levels began to increase significantly ~150 min after the onset of clonidine, rising continuously until the end of the experiment, in coincidence with Tc (Fig. 5, A and B). In contrast, the microdialysis of nimesulide or MK-0663 blocked the late rises of both Tc and PGE2 evoked by the microdialysis of clonidine alone; indeed, MK-0663 inverted the Tc rise into a significant fall, but neither had an effect on the early responses. PGE2 levels changed significantly in close temporal correlation with these thermal courses (Fig. 5, C–F). None of the COX inhibitors or their vehicle, DMSO, microdialyzed for 6 h, significantly affected the Tc or the intra-POA PGE2 levels of the guinea pigs (not illustrated).



View larger version (20K):
[in this window]
[in a new window]
  		Fig. 5. Effects on Tc and preoptic PGE2 levels, respectively, of the COX-1 inhibitor SC-560 + clonidine (A and B) and the COX-2 inhibitors nimesulide + clonidine (C and D) and MK-0663 (E and F) + clonidine microdialyzed into the POA of conscious guinea pigs. Abbreviations and conventions as in Fig. 2. *P < 0.05.

 
Experiment 3: Validation of Preoptic NE Effects

The intra-POA microdialysis of prazosin for 1 h before that of NE attenuated the initial Tc fall caused by NE alone but did not alter the late rises of Tc and intra-POA PGE2 levels induced by NE (Fig. 2, E and F). Thus the Tc increased gradually, beginning ~180 min after the start of the perfusion of NE and reaching a significant elevation of ~1°C by the end of the experiment. PGE2 levels again changed in close correlation with the thermal courses (Fig. 6, A and B). Yohimbine microdialyzed intra-POA for 1 h before NE also prevented the early fall of Tc and the late rises of Tc and PGE2 levels induced by NE. Similarly, MK-0663 completely abolished the Tc and PGE2 level changes evoked by NE. Indeed, MK-0663 inverted both the Tc and PGE2 late rises into falls, in close correlation with each other (Fig. 6, C-F).



View larger version (22K):
[in this window]
[in a new window]
  		Fig. 6. Effects on Tc and preoptic PGE2 levels, respectively, of the {alpha}1-AR antagonist prazosin + NE (A and B), the {alpha}2-AR antagonist yohimbine + NE (C and D), and the COX-2 inhibitor MK-0663 + NE (E and F) microdialyzed into the POA of conscious guinea pigs. Abbreviations and conventions as in Fig. 2. *P < 0.05.

 
The initial Tc falls produced by both NE (Fig. 2E) and clonidine (Fig. 4A) were abrogated when cirazoline and clonidine were microdialyzed together (Fig. 7A). However, the late Tc rises induced by both NE and clonidine were still evident. Thus Tc increased progressively from ~200 min after the onset of the perfusion until the end of the experiment (to ~1.2°C above Tci). Preoptic PGE2 levels, on the other hand, decreased significantly promptly after the onset of the experimental treatment and remained low for ~180 min and then increased in correlation with the late Tc rise (Fig. 7B), analogously to the full response to clonidine (Fig. 4B) and the late response to NE (Fig. 2F).



View larger version (18K):
[in this window]
[in a new window]
  		Fig. 7. Effects on Tc (A) and preoptic PGE2 levels (B) of the {alpha}1-AR agonist cirazoline + the {alpha}2-AR agonist clonidine microdialyzed together into the POA of conscious guinea pigs. Abbreviations and conventions as in Fig. 2. *P < 0.05.

 

   DISCUSSION
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
GRANTS
 REFERENCES
 
The selective {alpha}1-AR agonist cirazoline induced in this study prompt Tc rises without affecting basal preoptic PGE2 levels, whereas the selective {alpha}2-AR agonist clonidine caused early Tc falls and delayed Tc rises, both associated with parallel changes in the levels of POA PGE2. The thermal effects of both these agonists were validated by their blockade by their respective antagonists, prazosin and yohimbine. Furthermore, both the increases in Tc and POA PGE2 levels caused by clonidine were prevented by the intra-POA microdialysis of the COX-2 inhibitors nimesulide and MK-0663, but only the initial decreases of these variables were suppressed by that of the COX-1 inhibitor SC-560. (Because the hyperthermic effect of cirazoline was not accompanied by changes in the levels of POA PGE2, the effects of the COX inhibitors were not tested in its regard.) The intra-POA microdialysis of NE reproduced the early and the late Tc and preoptic PGE2 level changes induced by clonidine but not the early Tc rise evoked by cirazoline; both the clonidine-mediated effects were inhibited by yohimbine and MK-0663 but not by prazosin. Cirazoline and clonidine microdialyzed together replicated the late Tc rises but not the early Tc falls elicited by clonidine and NE and also not the early Tc rises caused by cirazoline; on the other hand, it induced both the POA PGE2 falls and rises associated with clonidine and NE. The present results thus indicate that {alpha}-AR agonists microdialyzed into the POA of conscious guinea pigs evoke differentially mediated Tc responses. To the best of our knowledge, they are also the first demonstration in the nervous system that the induction of postsynaptic PGE2 by presynaptic NE is mediated by {alpha}2-ARs and modulated by COX-2.

Although the presence of {alpha}1-ARs on thermosensitive neurons in the POA has been demonstrated previously by various means (35, 37), the thermal responses of different species to intra-POA microinjected {alpha}1-AR agonists have generally been inconsistent (9, 10). Indeed, we found in a previous study (50) that the {alpha}1-AR agonist methoxamine microdialyzed into the POA of conscious guinea pigs for 3 h had no thermal effect. The very prompt hyperthermic response to the specific {alpha}1-AR agonist cirazoline observed in this study was therefore unexpected. We have no explanation at this time for the discrepant responses to the two drugs other than to speculate that they may be accounted for by the lower potency of methoxamine compared with cirazoline (8, 63). The possibility that cirazoline may have leaked out of the central nervous system and acted on peripheral vascular {alpha}1-ARs, causing cutaneous vasoconstriction, seems remote because the dose that was microdialyzed intra-POA in this study was effectively ~1,000 times lower than its minimally effective vasoconstrictive dose (18, 37). It is also possible that the observed Tc rises may have been caused by a stimulatory action of cirazoline not mediated by {alpha}1-ARs, but this too is unlikely since its hyperthermic effect was inhibited by the specific {alpha}1-AR antagonist prazosin (Fig. 3). Significantly, the cirazoline-induced hyperthermia occurred in this instance without any associated changes in the levels of intra-POA PGE2; i.e., it was evoked quickly and without the intermediation of PGE2. This finding is novel and suggests that its mode of action on neurons is direct. We propose therefore (Fig. 8) that the activation of {alpha}1-ARs on postsynaptic warm-sensitive or thermoinsensitive neurons directly reduces or augments, respectively, the activities of these neurons, both responses promoting heat conservation according to the models of Hammel (19) and Boulant (7). Since these neurons, moreover, are thought to inhibit synaptically connected cold-sensitive neurons, these are concomitantly facilitated, stimulating heat production (not illustrated). The combination of these effector mechanisms raises Tc. The eventual decline of the hyperthermic action of cirazoline observed in the present study was presumably due to the desensitization of the relevant postsynaptic neurons, since prolonged exposure to a transmitter can gradually attenuate the responsiveness of neurons that originally were activated by it. The specific {alpha}1-AR subclass involved in this hyperthermic effect remains to be identified; Mallick et al. (34) have reported that the NE-stimulated increase in sodium pump activity of rat brain homogenates is mediated by {alpha}1A-ARs. Based on the foregoing, the present results would imply that NE released endogenously in the POA should exert a prompt hyperthermic action mediated by quickly activated postsynaptic {alpha}1-ARs. A discrepancy, however, appears to exist: the presence of NE, as mimicked by its intra-POA microdialysis, induced a Tc fall rather than a Tc rise; it will be addressed later.



View larger version (26K):
[in this window]
[in a new window]
  		Fig. 8. Proposed mechanism of the thermogenic interaction of NE and PGE2 in the POA of guinea pigs. See text for details. Modified from Ref. 5.

 
The intra-POA microdialysis of the {alpha}2-AR agonist clonidine evoked in this study a biphasic thermal response, viz., an initial, early decrease in Tc followed by a late, extended Tc rise. Clonidine has consistently been reported to evoke Tc falls when microinjected intra-POA in various species (39, 55). In our own previous studies (50, 51), it also induced dose-dependent Tc falls in conscious guinea pigs when microdialyzed intra-POA for 3 h at doses from 0.5 to 10 µg/µl. It did so again in the present study, at 2 µg/µl (Fig. 4). {alpha}2-ARs occur on both presynaptic and postsynaptic neurons. The identity of their subclasses specifically involved in this effect was not investigated in the present study; in mice, both {alpha}2A- and {alpha}2C-ARs have been implicated in the hypothermic action of clonidine (24, 28, 58).

In the present study, this hypothermic response was accompanied, moreover, by a concurrent decrease in the animals' preoptic PGE2 levels, a new finding. Like the Tc fall, it was blocked by pretreatment with the selective {alpha}2-AR antagonist yohimbine. Unexpectedly, both the Tc and PGE2 falls were also prevented by pretreatment with the COX-1 inhibitor SC-560 (Fig. 5). At least two possibilities could account for the latter surprising findings. Both tentatively involve the second messenger cAMP. Thus 1) various lines of evidence have indicated that NE induces the production of cAMP in first-order neurons in hypothalamic tissue slices (17); it is controversial, however, whether it does so by stimulating {alpha}1- or {alpha}2-ARs (52, 59). It was also reported long ago (11, 12) that the intra-POA microinjection of its analog agonist, dibutyryl-cAMP, into rabbits and rats causes a rapid fall followed by a prolonged rise in Tc and that the latter rise is blocked by acetaminophen, then a nonspecific COX inhibitor, but lately a putatively specific inhibitor of the presumptive COX-1 variant, COX-3 (61). This late rise was attributed to PGE2 generated in consequence of tissue damage associated with the microinjection procedure per se. Finally in this regard, it has also been shown that cAMP increases the activity of rat preoptic warm-sensitive neurons in slice preparations (7), an effect that would promote heat loss and, consequently, a Tc fall (7, 19). Taken together, these data infer that the clonidine-induced fall in Tc observed in the present study could have been due to the hypothermic action of cAMP released by {alpha}2-ARs (since the effect was blocked by yohimbine pretreatment). This explication is insufficient, however, to also account for the decrease in preoptic PGE2 that accompanied this Tc fall. Hence, 2) it could be that the stimulation by clonidine of postsynaptic {alpha}2-ARs also rapidly activates COX-1 (since the effect was blocked by SC-560) and induces the preferential production of PGD2. cAMP is a well-known activator of COX expression (44), and, from a strictly stoichiometric point of view, if under these conditions PGD synthase were activated relative to (presumably cytosolic) PGE synthase, one would expect less PGE2 and more PGD2 to be produced; both synthases are downstream of COX-1 and would be competing for the same, initially limited substrate, arachidonic acid. PGD2 has been shown to be hypothermic in various species (69), including guinea pigs (4), and it is also more abundant in brain than PGE2 (20). COX-1 is expressed constitutively in most cells, including neurons, and its PG products mediate basic physiological functions in normal tissue; the involvement of COX-1-dependent PGD2 in the observed effects is, therefore, quite plausible. Indeed, its blockade would prevent them, as was observed in this study. COX-1 blockade, however, does not affect the basal level of preoptic PGE2 (not illustrated).

The continued microdialysis of clonidine converted the initial Tc and preoptic PGE2 falls into concurrent, protracted increases (Fig. 4). Because both these rises were also inhibited by yohimbine pretreatment, they too were evidently {alpha}2-AR mediated; and because, moreover, they were prevented by the prior microdialysis of the selective COX-2 inhibitors nimesulide and MK-0663, this late hyperthermic response was mediated by COX-2-dependent PGE2. The production of PGE2 by NE is well documented (23, 33, 60), but the AR subtype and COX isoform that mediate PGE2 production were not identified in those earlier studies. The present data thus add the information that this response is {alpha}2-AR mediated and specifically catalyzed by COX-2. COX-2 is expressed constitutively in brain cells, and various studies have demonstrated that, although both COX-1 and COX-2 enzymes are upregulated by various inflammatory stimuli, COX-2 is the more readily inducible isoform (72). Its induction in this study could have been initiated by cAMP simultaneously with its activation of COX-1. One to 4 h are required for new gene expression and translation of COX-2 in LPS-activated phagocytic, endothelial, and other relevant cells ex vivo and in vivo (25, 48, 77), a duration that coincides with the interval between the onset of the microdialysis of clonidine and NE and the beginning of the rises of Tc and the levels of POA PGE2 induced by both these agonists in the present study (Figs. 2 and 4). The involvement of COX-2 under the present experimental conditions is therefore also concordant. In support, the late hyperthermic response to clonidine microinjected intracerebroventricularly into conscious mice is suppressed in COX-2 gene-ablated animals (unpublished observation). Although we have previously observed a biphasic hypo-/hyperthermic response to intra-POA microinjected (rather than microdialyzed) clonidine (55), in that study in contrast to the present one, the {alpha}2-AR antagonist rauwolscine microinjected 10 min before clonidine abolished the hypothermia without affecting the subsequent hyperthermia; the latter was attenuated by the intramuscular injection of the nonspecific COX inhibitor indomethacin 20 min after the intra-POA microinjection of clonidine. This response was similar to that to dibutyryl-cAMP reported by Dascombe (11, 12). We interpreted those data as verifying the {alpha}2-AR-mediated hypothermic action of clonidine and, like Dascombe, attributed the subsequent Tc rise to contamination of the thermal response to this agonist by PGE2 released in the POA consequent to the acute inflammatory response to the microinjection procedure per se (57). However, in view of the present findings, we now suggest that the late reduced hyperthermic response to microinjected clonidine observed in that previous study (55) was also partly accomplished by {alpha}2-AR-mediated, as contrasted only to injury-induced, upregulation of COX-2-dependent PGE2.

The brain cell type(s) expressing COX-2 in the present instance was not investigated, but the increase of COX-2 after, for example, the peripheral administration of LPS is observed in astrocytes, microglia, perivascular cells, and cerebromicrovascular endothelial cells but only irregularly in neurons (16, 29, 36, 48, 71); neurons, in any case, secrete only small amounts of PGE2 (22). Hence, we conjecture that the PGE2 collected in the microdialysate effluents from the POA extracellular space in the present experiments was generated by astrocytic processes contacting noradrenergic synaptic regions rather than by postsynaptic neurons (41). We propose therefore (Fig. 8) that the evoked release of NE by discharging presynaptic noradrenergic neurons stimulates astrocytic {alpha}2-ARs, generating arachidonic acid from membrane phospholipids; PGE2 is then formed by the action of COX-2 on the arachidonic acid. Which phospholipase (PL) forms are activated and how COX-2 and microsomal PGE synthase are upregulated under these conditions remain to be determined. In rat vascular smooth muscle cells, NE-stimulated postjunctional {alpha}2-ARs activate cytosolic PLA2 [isoforms not identified (45)], but NE also binds to {alpha}2-ARs coupled to phosphoinositide-specific phospholipases (PI-PL) C and D (45). In rat hypothalami, LPS upregulates secretory PLA2-IIA [cell types not identified (25)]. The mode of action of PGE2 on the activities of POA warm-sensitive and thermoinsensitive neurons is similar to that suggested earlier for {alpha}1-AR-mediated responses, viz., a reduction and an increase in firing rates, respectively (53). The PGE2-sensitive receptor involved in these neuronal effects may be the EP3 and/or EP4 subtypes; both have been linked to the development of fever and are present in the POA (15, 42, 43, 70, 76).

Although extensive, the data on the thermoregulatory actions of central NE are inconsistent, some indicating that NE reduces, others that it increases, and still others that it does not influence Tc (47, 49–51, 75). The discrepant results have been hard to reconcile because the methodologies, species, and doses employed by different investigators varied greatly. Indeed, we found, in common with other workers (66, 67, 75), that NE microinjected into the POA of conscious guinea pigs caused a rise in Tc but that, when microdialyzed, it evoked a hypothermic response (49–51). We attributed the Tc fall in the latter case to an artifact of the low pH (~3.5) of our perfusate and the neurotoxic effect of the potent antioxidant (sodium metabisulfite) present in that solution (Levophed). However, in that study, we discontinued the perfusion after 3 h and therefore missed its subsequent effects. The present finding that the intra-POA microdialysis of NE for 6 h induced first a fall (as before) and then a rise in both Tc and POA PGE2 levels (analogous to the biphasic response to clonidine) and that both these effects were inhibited by yohimbine thus indicates that this biphasic response represents the authentic mode of action of NE microdialyzed for 6 h into the POA, i.e., that neither the observed falls nor the rises of these two variables were artifactitious and that both events were mediated by {alpha}2-AR stimulation. On the other hand, the coadministration of cirazoline and clonidine, to mimic NE without its vehicle, 0.1% ascorbic acid, did not reproduce the initial NE-induced hypothermia although the fall in POA PGE2 was still evident. We ascribe the absence of a fall in Tc under these conditions to the observed, opposite thermal actions of these agonists, i.e., the direct, {alpha}1-AR-stimulated elevation of Tc by cirazoline was counteracted by the clonidine, {alpha}2-AR-mediated induction of, presumptively, cAMP/PGD2 and the consequent depression of Tc. It is not clear, however, why then the {alpha}2-AR-mediated, hypothermic action of NE was not similarly antagonized by its {alpha}1-AR-mediated, hyperthermic effect, and why also the blockade of the latter effect by prazosin did not enhance the Tc fall. However, because the NE and combined cirazoline-clonidine solutions differed in this study only by the presence of ascorbic acid in the former, it is possible that the acidity of that additive accounted for the different effects. Indeed, the hypothermic effect of NE was larger than that of ascorbic acid yet smaller than that of clonidine. Because, furthermore, the NE- and clonidine-induced decreases in POA PGE2 levels were relatively similar, we speculate that pH could be more determinative of neuronal discharge activity ({alpha}1-AR) than of astrocytic signal transduction ({alpha}2-AR). Indeed, we found in an earlier study (60) that the intra-POA microdialysis of Levophed similarly abrogated the NE-induced changes in Tc but not those in PGE2.

Discounting, then, the possible, confounding effect of the acidity of the NE solution and assuming that the observed responses to coadministered cirazoline and clonidine represent those of buffered NE, we conjecture that the hypothermic effect of endogenous NE released in the POA in response to a peripheral stimulus, in contrast to exogenous NE microdialyzed continuously into the POA, could be masked whereas its simultaneously activated hyperthermic effects could be manifested and occur in succession, i.e., the first (cirazoline) rapid in onset, {alpha}1-AR mediated and PGE2 independent, and the second (clonidine) delayed, {alpha}2-AR mediated and COX-2/PGE2 dependent. If existent, such a mechanism could be pertinent to a postulated mechanism of the febrile response to peripheral LPS that posits that the pyrogenic message may be transmitted to the brain by vagal afferents, ultimately arriving in the POA via ascending noradrenergic projections (6, 62, 73). To wit, the febrile response of guinea pigs to intravenous LPS is characteristically biphasic, and COX-2 plays a greater role in the late than in the early phase of the fever (64). If validated, this would implicate intra-POA NE pivotally in the modulation of the febrile response to LPS.


   GRANTS
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
REFERENCES
 
This work was supported by National Institutes of Health Grant NS-38594 to C. M. Blatteis and by Merck-Sharpe Dohm.


   FOOTNOTES
 

Address for reprint requests and other correspondence: C. M. Blatteis, Dept. of Physiology, The Univ. of Tennessee Health Science Center, 894 Union Ave., Memphis, TN 38163 (E-mail: blatteis{at}physio1.utmem.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


   REFERENCES
TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 GRANTS
 REFERENCES
 

  1. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 283: R281–R283, 2002.[Free Full Text]
  2. Arbuthnott GW, Crow TJ, Fuxe K, Olson L, and Ungerstedt U. Depletion of catecholamines in vivo induced by electrical stimulation of central monoamine pathways. Brain Res 24: 471–483, 1970.[CrossRef][Medline]
  3. Bergstrom S, Farnebo LO, and Fuxe K. Effect of prostaglandin E2 on central and peripheral catecholamine neurons. Eur J Pharmacol 21: 362–368, 1973.[CrossRef][ISI][Medline]
  4. Blatteis CM, Mashburn TA Jr, Llanos QJ, and Ahokas RA. Thermal and acute phase glycoprotein responses of guinea pigs to intrapreoptically injected PGD2, PGF2, and PGl2. Fed Proc 44: 438, 1985.
  5. Blatteis CM and Sehic E. Prostaglandin E2: a putative fever mediator. In: Fever: Basic Mechanisms and Management (2nd ed.), edited by Mackowiak PA. Philadelphia, PA: Lippincott-Raven, 1997, p. 117–145.
  6. Blatteis CM, Sehic E, and Li S. Pyrogen sensing and signaling: old views and new concepts. Clin Infect Dis 31: 168–177, 2000.[CrossRef]
  7. Boulant JA. Hypothalamic neurons regulating body temperature. In: Handbook of Physiology. Environmental Physiology. Bethesda, MD: Am. Physiol. Soc., 1996, sect. 4, vol. I, chapt. 6, p. 105–126.
  8. Buckner SA, Oheim KW, Morse PA, Knepper SM, and Hancock AA. Alpha 1-adrenoceptor-induced contractility in rat aorta is mediated by the alpha 1D subtype. Eur J Pharmacol 297: 241–248, 1996.[CrossRef][ISI][Medline]
  9. Clark WG. Changes in body temperature after administration of antipyretics, LSD, delta 9-THC and related agents. II. Neurosci Biobehav Rev 11: 35–96, 1987.[CrossRef][ISI][Medline]
  10. Clark WG and Lipton JM. Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants. II. Neurosci Biobehav Rev 10: 153–220, 1986.[CrossRef][ISI][Medline]
  11. Dascombe MJ. Evidence against cyclic adenosine 3',5'-monophosphate as a mediator of fever in the brain. Neuropharmacology 25: 309–313, 1986.[CrossRef][ISI][Medline]
  12. Dascombe MJ. Evidence that cyclic nucleotides are not mediators of fever in rabbits. Br J Pharmacol 81: 583–588, 1984.[ISI][Medline]
  13. Dray F and Heaulme M. Prostaglandins of the E series inhibit release of noradrenaline in rat hypothalamus by a mechanism unrelated to classical {alpha}2 adrenergic presynaptic inhibition. Neuropharmacology 23: 457–462, 1984.[CrossRef][ISI][Medline]
  14. Dunn AJ and Wang J. Cytokine effects on CNS biogenic amines. Neuroimmunomodulation 2: 319–328, 1995.[ISI][Medline]
  15. Ek M, Arias C, Sawchenko P, and Ericsson-Dahlstrand A. Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J Comp Neurol 428: 5–20, 2000.[CrossRef][ISI][Medline]
  16. Elmquist JK, Breder CD, Sherin JE, Scammell TE, Hickey WF, Dewitt D, and Saper CB. Intravenous lipopolysaccharide induces cyclooxygenase 2-like immunoreactivity in rat brain perivascular microglia and meningeal macrophages. J Comp Neurol 381: 119–129, 1997.[CrossRef][ISI][Medline]
  17. Etgen AM and Petitti N. Mediation of norepinephrine-stimulated cyclic AMP accumulation by adrenergic receptors in hypothalamic and preoptic area slices: effects of estradiol. J Neurochem 49: 1732–1739, 1987.[CrossRef][ISI][Medline]
  18. Hales JR, Foldes A, Fawcett AA, and King RB. The role of adrenergic mechanisms in thermoregulatory control of blood flow through capillaries and arteriovenous anastomoses in the sheep hind limb. Pflügers Arch 395: 93–98, 1982.[CrossRef][ISI][Medline]
  19. Hammel HT. Neurons and temperature regulation. In: Physiological Controls and Regulations, edited by Yamamoto WS and Brobeck JR. Philadelphia, PA: Saunders, 1965, p. 71–97.
  20. Hayaishi O. Prostaglandin D2 and sleep a molecular genetic approach. J Sleep Res 1: 60–64, 1999.[CrossRef]
  21. Hedqvist P. Basic mechanisms of prostaglandin action on autonomic neurotransmission. Annu Rev Pharmacol Toxicol 17: 259–279, 1977.[CrossRef][ISI][Medline]
  22. Hertting G and Seregi A. Formation and function of eicosanoids in the central nervous system. Ann NY Acad Sci 559: 84–99, 1989.[ISI][Medline]
  23. Hillier K, Roberts PJ, and Woollard PM. Catecholamine-stimulated prostaglandin synthesis in rat brain synaptosomes. Br J Pharmacol 58: 426–427, 1976.
  24. Hunter JC, Fontana DJ, Hedley LR, Jasper JR, Lewis R, Link RE, Secchi R, Sutton J, and Eglen RM. Assessment of the role of {alpha}2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br J Pharmacol 122: 1339–1344, 1997.[CrossRef][ISI][Medline]
  25. Ivanov AI, Pero RS, Scheck AC, and Romanovsky AA. Prostaglandin E2-synthesizing enzymes in fever: differential transcriptional regulation. Am J Physiol Regul Integr Comp Physiol 283: R1104–R1117, 2002.[Abstract/Free Full Text]
  26. Kabiersch A, del Rey A, Honegger CG, and Besedovsky HO. Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun 2: 267–274, 1988.[CrossRef][Medline]
  27. Laburn H, Woolf CJ, Willies GH, Rosendorff C. Pyrogen and prostaglandin fever in the rabbit. II. Effects of noradrenaline depletion and adrenergic receptor blockade. Neuropharmacology 14: 405–411, 1975.[CrossRef][ISI][Medline]
  28. Lahdesmaki J, Sallinen J, MacDonald E, Sirvio J, and Scheinin M. Alpha 2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the {alpha}2A-adrenoceptor subtype. Neuropharmacology 44: 882–892, 2003.[CrossRef][ISI][Medline]
  29. Li S, Wang Y, Matsumura K, Ballou LR, Morham SG, and Blatteis CM. The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(–/–), but not in cyclooxygenase-1(–/–) mice. Brain Res 825: 86–94, 1999.[CrossRef][ISI][Medline]
  30. Lin MT. Brain monoamines act through the prostaglandin release to influence the body temperature. Chin J Physiol 22: 55–64, 1976.[Medline]
  31. Linthorst AC, Flachskamm C, Holsboer F, and Reul JM. Intraperitoneal administration of bacterial endotoxin enhances noradrenergic neurotransmission in the rat preoptic area: relationship with body temperature and hypothalamic-pituitary-adrenocortical axis activity. Eur J Neurosci 7: 2418–2430, 1995.[CrossRef][ISI][Medline]
  32. Luparello TJ. Stereotaxic Atlas of the Forebrain of the Guinea Pig. Basel: Karger, 1967.
  33. Malik KU and Sehic E. Prostaglandins and the release of the adrenergic transmitter. Ann NY Acad Sci 604: 222–236, 1990.[ISI][Medline]
  34. Mallick BN, Adya HV, and Faisal M. Norepinephrine-stimulated increase in Na+,K+-ATPase activity in the rat brain is mediated through {alpha}1A-adrenoceptor possibly by dephosphorylation of the enzyme. J Neurochem 74: 1574–1578, 2000.[CrossRef][ISI][Medline]
  35. Mallick BN, Jha SK, and Islam F. Presence of {alpha}1 adrenoreceptors on thermosensitive neurons in the medial preoptico-anterior hypothalamic area in rats. Neuropharmacology 42: 697–705, 2002.[CrossRef][ISI][Medline]
  36. Matsumura K, Cao C, Ozaki M, Morii H, Nakadate K, and Watanabe Y. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. J Neurosci 18: 6279–6289, 1998.[Abstract/Free Full Text]
  37. Medgett IC and Ruffolo RR Jr. Alpha adrenoceptor-mediated vasoconstriction in rat hindlimb: innervated {alpha}-2 adrenoceptors in the saphenous arterial bed. J Pharmacol Exp Ther 246: 249–254, 1988.[Abstract/Free Full Text]
  38. Mefford IN and Heyes MP. Increased biogenic amine release in mouse hypothalamus following immunological challenge: antagonism by indomethacin. J Neuroimmunol 27: 55–61, 1990.[CrossRef][ISI][Medline]
  39. Myers RD, Beleslin DB, and Rezvani AH. Hypothermia: role of {alpha}1- and {alpha}2-noradrenergic receptors in the hypothalamus of the cat. Pharmacol Biochem Behav 26: 373–379, 1987.[CrossRef][ISI][Medline]
  40. Myers RD and Waller MB. Is prostaglandin fever mediated by the presynaptic release of hypothalamic 5-HT or norepinephrine? Brain Res Bull 1: 47–56, 1976.[CrossRef][ISI][Medline]
  41. Newman E. New roles of astrocytes: regulation of synaptic transmission. Trends Neurosci 10: 536–542, 2003.
  42. Oka T, Oka K, Kobayashi T, Sugimoto Y, Ichikawa A, Ushikubi F, Narumiya S, and Saper CB. Characteristics of thermoregulatory and febrile responses in mice deficient in prostaglandin EP1 and EP3 receptors. J Physiol 551: 945–954, 2003.[Abstract/Free Full Text]
  43. Oka T, Oka K, Scammell TE, Lee C, Kelly JF, Nantel F, Elmquist JK, and Saper CB. Relationship of EP(1–4) prostaglandin receptors with rat hypothalamic cell groups involved in lipopolysaccharide fever responses. J Comp Neurol 428: 20–32, 2000.[CrossRef][ISI][Medline]
  44. Oshima T, Yoshimoto T, Yamamoto S, Kumegawa M, Yokoyama C, and Tanabe T. cAMP-dependent induction of fatty acid cyclooxygenase mRNA in mouse osteoblastic cells (MC3T3–E1). J Biol Chem 266: 13621–13626, 1991.[Abstract/Free Full Text]
  45. Parmentier JH, Muthalif MM, Saeed AE, and Malik KU. Phospholipase D activation by norepinephrine is mediated by 12(s)-, 15(s)-, and 20-hydroxyeicosatetraenoic acids generated by stimulation of cytosolic phospholipase A2 tyrosine phosphorylation of phospholipase D2 in response to norepinephrine. J Biol Chem 276: 15704–15711, 2001.[Abstract/Free Full Text]
  46. Quan N and Blatteis CM. Microdialysis: a system for localized drug delivery into the brain. Brain Res Bull 22: 621–625, 1989.[CrossRef][ISI][Medline]
  47. Quan N and Blatteis CM. Intrapreoptically microdialyzed and microinjected norepinephrine evokes different thermal responses. Am J Physiol Regul Integr Comp Physiol 257: R816–R821, 1989.[Abstract/Free Full Text]
  48. Quan N, Whiteside M, and Herkenham M. Cyclooxygenase 2 mRNA expression in rat brain after peripheral injection of lipopolysaccharide. Brain Res 802: 189–197, 1998.[CrossRef][ISI][Medline]
  49. Quan N, Xin L, and Blatteis CM. Microdialysis of norepinephrine into preoptic area of guinea pigs: characteristics of hypothermic effect. Am J Physiol Regul Integr Comp Physiol 261: R378–R385, 1991.[Abstract/Free Full Text]
  50. Quan N, Xin L, Ungar AL, and Blatteis CM. Preoptic norepinephrine-induced hypothermia is mediated by {alpha}2-adrenoceptors. Am J Physiol Regul Integr Comp Physiol 262: R407–R411, 1992.[Abstract/Free Full Text]
  51. Quan N, Xin L, Ungar AL, Hunter WS, and Blatteis CM. Validation of the hypothermic action of preoptic norepinephrine in guinea pigs. Brain Res Bull 28: 537–542, 1992.[CrossRef][ISI][Medline]
  52. Quesada A and Etgen AM. Tyrosine kinase effects on adrenoceptor-stimulated cyclic AMP accumulation in preoptic area and hypothalamus of female rats: modulation by estradiol. Brain Res 861: 117–125, 2000.[CrossRef][ISI][Medline]
  53. Ranels HJ and Griffin JD. The effects of prostaglandin E2 on the firing rate activity of thermosensitive and temperature insensitive neurons in the ventromedial preoptic area of the rat hypothalamus. Brain Res 964: 42–50, 2003.[CrossRef][ISI][Medline]
  54. Reimann W, Steinhauer HB, Hedler L, Starke K, and Hertting G. Effect of prostaglandins D2, E2 and F2{alpha} on catecholamine release from slices of rat and rabbit brain. Eur J Pharmacol 69: 421–427, 1981.[CrossRef][ISI][Medline]
  55. Romanovsky AA, Shido O, Ungar AL, and Blatteis CM. Genesis of biphasic thermal response to intrapreoptically microinjected clonidine. Brain Res Bull 31: 509–513, 1993.[CrossRef][ISI][Medline]
  56. Romanovsky AA, Simons CT, and Kulchitsky VA. Biphasic fevers often consist of more than two phases. Am J Physiol Regul Integr Comp Physiol 275: R323–R331, 1998.[Abstract/Free Full Text]
  57. Rudy TA, Williams JW, and Yaksh TL. Antagonism by indomethacin of neurogenic hyperthermia produced by unilateral puncture of the anterior hypothalamic/preoptic region. J Physiol 272: 721–736, 1977.[Abstract/Free Full Text]
  58. Sallinen J, Link RE, Haapalinna A, Viitamaa T, Kulatunga M, Sjoholm B, Macdonald E, Pelto-Huikko M, Leino T, Barsh GS, Kobilka BK, and Scheinin M. Genetic alteration of {alpha}2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective {alpha}2-adrenoceptor agonist. Mol Pharmacol 51: 36–46, 1997.[Abstract/Free Full Text]
  59. Schaad NC, Schorderet M, and Magistretti PJ. Prostaglandins and the synergism between VIP and noradrenaline in the cerebral cortex. Nature 328: 637–640, 1987.[CrossRef][Medline]
  60. Sehic E, Ungar AL, and Blatteis CM. Interaction between norepinephrine and prostaglandin E2 in the preoptic area of guinea pigs. Am J Physiol Regul Integr Comp Physiol 271: R528–R536, 1996.[Abstract/Free Full Text]
  61. Simmons DL, Botting RM, Robertson PM, Madsen ML, and Vane JR. Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs. Proc Natl Acad Sci USA 96: 3275–3280, 1999.[Abstract/Free Full Text]
  62. Simons CT, Kulchitsky VA, Sugimoto N, Homer LD, Szekely M, and Romanovsky AA. Signaling the brain in systemic inflammation: which vagal branch is involved in fever genesis? Am J Physiol Regul Integr Comp Physiol 275: R63–R68, 1998.[Abstract/Free Full Text]
  63. Stam WB, Van der Graaf PH, and Saxena PR. Analysis of {alpha}1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol 127: 661–670, 1999.